A Clinical Update on Gestational Diabetes Mellitus

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Public Health

Background:

• Gestational diabetes mellitus (GDM) is defined as abnormal glucose tolerance during pregnancy.
• GDM is associated with adverse obstetric and neonatal outcomes, including higher infant birthweight.
• Its prevalence is increasing due to factors like rising maternal obesity and age, and revised diagnostic criteria.

Purpose of the Study:

• To emphasize the need for a contemporary clinical approach to GDM that considers both short-term and long-term prognoses.
• To highlight GDM as a significant risk factor for future maternal and offspring cardiometabolic diseases.
• To underscore the importance of early identification of GDM for intergenerational health.

Main Methods:

• Review of current literature and epidemiological data on GDM prevalence and impact.
• Analysis of recent findings on the effects of in utero hyperglycemia on fetal development and long-term metabolism.
• Synthesis of evidence linking GDM to increased risk of type 2 diabetes and cardiovascular disease.

Main Results:

• Maternal hyperglycemia in utero can lead to fetal overgrowth even before GDM diagnosis.
• Adverse effects of maternal hyperglycemia on child and adolescent metabolism are durable.
• GDM significantly contributes to the global epidemic of intergenerational cardiometabolic disease.

Conclusions:

• The clinical approach to GDM must extend beyond immediate pregnancy complications to address long-term maternal and offspring health.
• Identifying GDM as an early risk factor for type 2 diabetes and cardiovascular disease is critical.
• Comprehensive management strategies are needed to mitigate the intergenerational cardiometabolic risks associated with GDM.